Supporting evidence for this hypothesis includes the disproportionately higher proportion of adenocarcinoma and EGFR mutations in lung tumors among never-smokers, along with additional clinical and pathological differences between the two tumors [3]. Here, EGFR is linked to adenocarcinoma.